NeuroPace, Inc. (NPCE)
NASDAQ: NPCE · Real-Time Price · USD
16.97
+0.19 (1.13%)
At close: Jul 9, 2026, 4:00 PM EDT
16.98
+0.01 (0.06%)
After-hours: Jul 9, 2026, 5:56 PM EDT
NeuroPace Market Cap
NeuroPace has a market cap or net worth of $578.57 million as of July 9, 2026. Its market cap has increased by 63.94% in one year.
Market Cap
578.57M
Enterprise Value
590.96M
1-Year Change
63.94%
Ranking
Category
Stock Price
$16.97
Market Cap Chart
Since the IPO on April 22, 2021, NeuroPace's market cap has increased from $393.28M to $578.57M, an increase of 47.11%. That is a compound annual growth rate of 7.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 578.57M | 12.50% |
| Dec 31, 2025 | 514.27M | 53.97% |
| Dec 31, 2024 | 334.00M | 23.25% |
| Dec 29, 2023 | 270.98M | 630.30% |
| Dec 30, 2022 | 37.11M | -84.86% |
| Dec 31, 2021 | 245.09M | -37.68% |
| Apr 22, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SS Innovations International | 720.47M |
| Tactile Systems Technology | 676.24M |
| Cerus | 629.16M |
| BrainsWay | 604.29M |
| Cytek Biosciences | 566.94M |
| ClearPoint Neuro | 518.52M |
| OrthoPediatrics | 507.54M |
| Orthofix Medical | 466.47M |